Phase I study of escalating doses of low-dose-rate, locoregional irradiation preceding Cytoxan-TBI for patients with chemotherapy-resistant non-Hodgkin's or Hodgkin's lymphoma.

Phase I study of escalating doses of low-dose-rate, locoregional irradiation preceding Cytoxan-TBI for patients with chemotherapy-resistant non-Hodgkin's or Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys. 2003 Sep 01; 57(1):166-71.

View in: PubMed

subject areas

Adolescent
Adult
Aged
Bone Marrow Transplantation
Combined Modality Therapy
Cyclophosphamide
Dose-Response Relationship, Radiation
Hodgkin Disease
Humans
Lymphoma, Non-Hodgkin
Maximum Tolerated Dose
Middle Aged
Radiotherapy Dosage
Treatment Outcome
Whole-Body Irradiation

authors with profiles

Ross Abrams